NANOREPRO AG (NN6.DE) Stock Fundamental Analysis
Europe - FRA:NN6 - DE0006577109 - Common Stock
1.785 EUR
+0.06 (+3.78%)
NN6 gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 62 industry peers in the Health Care Equipment & Supplies industry. NN6 has a great financial health rating, but its profitability evaluates not so good. NN6 shows excellent growth, but is valued quite expensive already.
1. Profitability
1.1 Basic Checks
In the past year NN6 has reported negative net income.
In the past year NN6 had a positive cash flow from operations.
In multiple years NN6 reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: NN6 reported negative operating cash flow in multiple years.
1.2 Ratios
Looking at the Return On Assets, with a value of -5.26%, NN6 is doing worse than 67.74% of the companies in the same industry.
NN6 has a Return On Equity of -5.39%. This is in the lower half of the industry: NN6 underperforms 67.74% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.26% | ||
| ROE | -5.39% | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
NN6 has a better Gross Margin (61.74%) than 61.29% of its industry peers.
NN6's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for NN6 so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 61.75% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y21.24%
GM growth 5Y-10.7%
2. Health
2.1 Basic Checks
NN6 does not have a ROIC to compare to the WACC, probably because it is not profitable.
NN6 has about the same amout of shares outstanding than it did 1 year ago.
NN6 has more shares outstanding than it did 5 years ago.
There is no outstanding debt for NN6. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
NN6 has an Altman-Z score of 16.07. This indicates that NN6 is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 16.07, NN6 belongs to the top of the industry, outperforming 95.16% of the companies in the same industry.
There is no outstanding debt for NN6. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 16.07 |
ROIC/WACCN/A
WACC7.33%
2.3 Liquidity
NN6 has a Current Ratio of 50.00. This indicates that NN6 is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of NN6 (50.00) is better than 100.00% of its industry peers.
NN6 has a Quick Ratio of 46.73. This indicates that NN6 is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 46.73, NN6 belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 50 | ||
| Quick Ratio | 46.73 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 56.76% over the past year.
The Revenue has grown by 40.57% in the past year. This is a very strong growth!
NN6 shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 29.69% yearly.
EPS 1Y (TTM)56.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)40.57%
Revenue growth 3Y-69.83%
Revenue growth 5Y29.69%
Sales Q2Q%50.84%
3.2 Future
NN6 is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.42% yearly.
NN6 is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 104.40% yearly.
EPS Next Y-1%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year232.82%
Revenue Next 2Y104.4%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
NN6 reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year NN6 is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
100.00% of the companies in the same industry are more expensive than NN6, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 2.42 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as NN6's earnings are expected to grow with 41.42% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 6.98%, NN6 is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.23, NN6 pays a better dividend. On top of this NN6 pays more dividend than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.31, NN6 pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.98% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y41.42%
EPS Next 3YN/A
FRA:NN6 (10/28/2025, 7:00:00 PM)
1.785
+0.06 (+3.78%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners9.03%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap23.03M
Revenue(TTM)4.47M
Net Income(TTM)-2050000
Analysts84
Price Target4.59 (157.14%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.98% |
Yearly Dividend0.15
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 5.15 | ||
| P/FCF | 2.42 | ||
| P/OCF | 2.34 | ||
| P/B | 0.6 | ||
| P/tB | 0.66 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.16
EYN/A
EPS(NY)-0.16
Fwd EYN/A
FCF(TTM)0.74
FCFY41.26%
OCF(TTM)0.76
OCFY42.82%
SpS0.35
BVpS2.96
TBVpS2.69
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.26% | ||
| ROE | -5.39% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 61.75% | ||
| FCFM | 212.53% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y21.24%
GM growth 5Y-10.7%
F-Score8
Asset Turnover0.11
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 1200% | ||
| Cap/Sales | 8.05% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 50 | ||
| Quick Ratio | 46.73 | ||
| Altman-Z | 16.07 |
F-Score8
WACC7.33%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)56.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y-1%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)40.57%
Revenue growth 3Y-69.83%
Revenue growth 5Y29.69%
Sales Q2Q%50.84%
Revenue Next Year232.82%
Revenue Next 2Y104.4%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y32.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year38.06%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y195%
FCF growth 3Y4.97%
FCF growth 5YN/A
OCF growth 1Y198.6%
OCF growth 3Y6.28%
OCF growth 5YN/A
NANOREPRO AG / NN6.DE FAQ
What is the ChartMill fundamental rating of NANOREPRO AG (NN6.DE) stock?
ChartMill assigns a fundamental rating of 5 / 10 to NN6.DE.
What is the valuation status for NN6 stock?
ChartMill assigns a valuation rating of 2 / 10 to NANOREPRO AG (NN6.DE). This can be considered as Overvalued.
What is the profitability of NN6 stock?
NANOREPRO AG (NN6.DE) has a profitability rating of 1 / 10.
Can you provide the financial health for NN6 stock?
The financial health rating of NANOREPRO AG (NN6.DE) is 9 / 10.